These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enterobacter sakazakii infection in the newborn. Bar-Oz B; Preminger A; Peleg O; Block C; Arad I Acta Paediatr; 2001 Mar; 90(3):356-8. PubMed ID: 11332182 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Sanders WE; Tenney JH; Kessler RE Clin Infect Dis; 1996 Sep; 23(3):454-61. PubMed ID: 8879764 [TBL] [Abstract][Full Text] [Related]
6. Risk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer. Huh K; Kang CI; Kim J; Cho SY; Ha YE; Joo EJ; Chung DR; Lee NY; Peck KR; Song JH Diagn Microbiol Infect Dis; 2014 Feb; 78(2):172-7. PubMed ID: 24321352 [TBL] [Abstract][Full Text] [Related]
7. Empirical third-generation cephalosporin therapy for adults with community-onset Enterobacteriaceae bacteraemia: Impact of revised CLSI breakpoints. Hsieh CC; Lee CH; Li MC; Hong MY; Chi CH; Lee CC Int J Antimicrob Agents; 2016 Apr; 47(4):297-303. PubMed ID: 27005458 [TBL] [Abstract][Full Text] [Related]
9. Enterobacter cloacae bacteremia in children: a review of 30 cases in 12 years. Bonadio WA; Margolis D; Tovar M Clin Pediatr (Phila); 1991 May; 30(5):310-3. PubMed ID: 2044341 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of children with enterobacteriaceae bacteremia with reduced susceptibility to ceftriaxone: do the revised breakpoints translate to improved patient outcomes? Tamma PD; Wu H; Gerber JS; Hsu AJ; Tekle T; Carroll KC; Cosgrove SE Pediatr Infect Dis J; 2013 Sep; 32(9):965-9. PubMed ID: 23470679 [TBL] [Abstract][Full Text] [Related]
11. Predictive value of prior colonization and antibiotic use for third-generation cephalosporin-resistant enterobacteriaceae bacteremia in patients with sepsis. Rottier WC; Bamberg YR; Dorigo-Zetsma JW; van der Linden PD; Ammerlaan HS; Bonten MJ Clin Infect Dis; 2015 Jun; 60(11):1622-30. PubMed ID: 25694654 [TBL] [Abstract][Full Text] [Related]
12. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli. Sklaver AR; Greenman RL; Hoffman TA Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135 [TBL] [Abstract][Full Text] [Related]
13. Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species. Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW Infect Control Hosp Epidemiol; 2005 Jan; 26(1):88-92. PubMed ID: 15693414 [TBL] [Abstract][Full Text] [Related]
14. Enterobacter sakazakii bacteraemia with multiple splenic abscesses in a 75-year-old woman: a case report. See KC; Than HA; Tang T Age Ageing; 2007 Sep; 36(5):595-6. PubMed ID: 17646217 [TBL] [Abstract][Full Text] [Related]
15. Relationship between ceftriaxone use and resistance to third-generation cephalosporins among clinical strains of Enterobacter cloacae. Muller A; Lopez-Lozano JM; Bertrand X; Talon D J Antimicrob Chemother; 2004 Jul; 54(1):173-7. PubMed ID: 15150164 [TBL] [Abstract][Full Text] [Related]
17. Enterobacter sakazakii infections among neonates, infants, children, and adults. Case reports and a review of the literature. Lai KK Medicine (Baltimore); 2001 Mar; 80(2):113-22. PubMed ID: 11307587 [TBL] [Abstract][Full Text] [Related]
19. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813 [TBL] [Abstract][Full Text] [Related]